Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Luteolin is a naturally occurring flavone found in a wide range of plants, including celery, parsley, broccoli, and various medicinal herbs (PubChem, CID 5280445). It is important to note that Luteolin is a small molecule bioactive compound (a phytochemical) rather than a biological target, such as a receptor, enzyme, or transporter, that therapeutic drugs are typically designed to modulate. Luteolin is widely recognized for its potent antioxidant and anti-inflammatory properties, which it exerts by scavenging reactive oxygen species and inhibiting pro-inflammatory mediators such as COX-2 and NF-κB (NIH, PMC2615542). In oncology research, Luteolin has demonstrated the ability to inhibit tumor growth, suppress angiogenesis, and sensitize cancer cells to traditional chemotherapeutic agents like cisplatin by modulating the PI3K/Akt and MAPK signaling pathways (PubMed, 29653245). While it holds significant therapeutic potential as a lead compound or dietary supplement, its application in clinical settings is currently hindered by its poor pharmacokinetic profile and potential for metabolic interference with other medications.
Luteolin acts as a multi-target bioactive ligand that inhibits various enzymes such as phosphodiesterase 4 (PDE4), cyclooxygenase-2 (COX-2), and various protein kinases, while also modulating key signaling pathways like NF-κB, PI3K/Akt, and MAPK/ERK (NIH, PMC2615542; PubMed, 18992367).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Luteolin.